Disney‘s run to its first Super Bowl touchdown in 20 years is in danger of being stymied by some serious defense. The company ...
Pop singer-songwriter Absolutely breaks down her Paracosm album and talks about working with sisters RAYE and Amma. Read the full Billboard interview.
During a hot weekend in Pioneertown, the High Desert Art Fair drew creatives in droves, including Shepard Fairey and Mark ...
WASHINGTON — Politico was forced to yank a controversial antismeitic cartoon depicting a blood-soaked President Trump and Israeli Prime Minister Benjamin Netanyahu with an oversized nose sitting among ...
If you’ve ever expressed even a passing desire to visit Walt Disney World, you may have had friends who raised their eyebrows, groaned or even sneered. The heart of their criticism isn’t just that ...
Instagram has added a new feature that many users have long requested. You can now rearrange photos or videos in a carousel after posting. The update was confirmed by Instagram chief Adam Mosseri in a ...
HOUSTON, March 12, 2026 (GLOBE NEWSWIRE)-- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“Plus” or the “Company”), a healthcare company developing and commercializing precision diagnostics and ...
CUMBERLAND, R.I.--(BUSINESS WIRE)--Neurotech Pharmaceuticals, Inc. (the “Company”) today provided an update on its ongoing transition to a commercial‑stage company following the first anniversary of ...
(Alliance News) - M&G PLC on Thursday reported strong full-year results with assets under management, net flows, adjusted operating profit and operating capital generation are all ahead of ...
Company reports continued clinical adoption, expanding reimbursement coverage, and established commercial manufacturing capacity Neurotech Pharmaceuticals, Inc. (the “Company”) today provided an ...
Disney stock is at a 10-month low, but it might not last. The media giant in track to continue delivering double-digit earnings growth through at least the next two fiscal years. The arrival of new ...
Scholar Rock outlines 2026 apitegromab BLA resubmission and commercial launch following FDA progress
CEO David Hallal stated that "Scholar Rock is poised for a transformative year in 2026," emphasizing the company's focus on delivering the world's first muscle-targeted therapy to children and adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results